New Page components
Banner background

What is CIDP?

Banner subtext

CIDP, or chronic inflammatory demyelinating polyneuropathy, is a rare medical condition where the immune system attacks healthy tissue. This primarily affects the nerves in a person’s arms and legs.

What causes CIDP?

To understand what causes CIDP, you need to understand the relationship between neurons and myelin:

CIDP attacks myelin

Myelin protects neurons

Nerves are made up of neurons, which deliver messages between the brain and the rest of the body to perform actions like picking up a cup or taking a step.

Myelin is a protective layer around a neuron—like insulation around a wire—that helps messages get to their destinations.

CIDP attacks myelin

CIDP attacks myelin

The immune system is designed to spot foreign germs in the body and fight them off.

But with CIDP, the immune system thinks the myelin in your arms or legs is foreign and attacks it. This causes the messages neurons deliver to be slowed or lost.

Symptoms of CIDP

The most common symptom experienced with CIDP is weakness in the arms and legs. Some people may also feel a prickling sensation and numbness. Symptoms can happen in waves, coming and going over time, or worsen gradually.

Symptoms of CIDP may include:

Weakness in arms and legs

Weakness in arms and legs

Loss of coordination

Loss of coordination and difficulty with walking or standing up

Difficulty

Difficulty with fine motor skills

Loss of reflexes

Loss of reflexes

Prickling

Prickling sensation and numbness

Pain and fatigue

Pain and fatigue

Your healthcare team
Not actual patient.

Your healthcare team

Once you’re diagnosed with CIDP, you will have a care team that includes neurologists, neuromuscular specialists, neurophysiologists, pharmacists, and nurses, among others. They will all work together with you on your CIDP treatment plan.

*Eligible, commercially insured patients may receive a maximum benefit of $12,500 per year or the cost of a patient’s co-pay in a 12-month period (whichever is less) for claims received by the program. No membership fees are required. Federal and state healthcare beneficiaries are not eligible. The PANZYGA Co-Pay Program is good only in the US and Puerto Rico. Terms and conditions/eligibility requirements apply. See full Terms and Conditions on the Financial assistance programs page.

Want to connect with other patients diagnosed with CIDP?

The GBS|CIDP Foundation offers education and support to individuals and families affected by CIDP

The link above is for your convenience. The website is neither owned nor controlled by Pfizer. Pfizer does not endorse and is not responsible for the content or services of the site.